REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...

My Alerts is a service for subscribers. Please login or subscribe in order to use My Alerts. An investigation is underway after a helicopter belonging to Saudi Aramco crashed, killing all 14 people ...

The expected move of Miles Bridges has gone down. After the blockbuster LaMelo Ball trade last week, the Charlotte Hornets have made another deal, sending Bridges to the Phoenix Suns, according to ...

A helicopter operated by Saudi Aramco crashed Sunday in the energy heartland of Ras Tanura, killing all 14 passengers on board. The crash took place at 6 a.m. local time, the Saudi Press Agency said , ...

SINGAPORE, June 26 (Reuters) - Saudi Aramco resumed crude loadings on Friday at its Ras Tanura terminal in the Gulf after a near four-month halt, shipping data showed, as the world's biggest oil ...

Qatar said it doesn’t expect liquefied natural gas exports to be impacted by an explosion at the Ras Laffan industrial complex which left 13 dead and 66 injured. Production has been halted at the ...

Authorities confirm deaths, say 66 injured Authorities say a 'technical accident' caused explosion Blast occurred during restart at Barzan gas supply facility DOHA, June 22 (Reuters) - Thirteen people ...

A Canadian who has worked in the gaming industry for over two decades, Beck grew up on games such as Final Fantasy and Super Mario Bros. He specalizes in roleplaying games, but covers titles in almost ...

An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.

A shift in the way people think about and treat pancreatic cancer could be on the horizon based on positive results from the pivotal randomized Phase III RASolute 302 trial comparing daraxonrasib to ...